TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $20,362,000 | -37.7% | 758,356 | +10.6% | 0.13% | -32.5% |
| Q4 2021 | $32,701,000 | -47.4% | 685,549 | -26.8% | 0.19% | -48.3% |
| Q3 2021 | $62,211,000 | -12.2% | 936,491 | +3.2% | 0.38% | -11.6% |
| Q2 2021 | $70,823,000 | +81.3% | 907,760 | +119.8% | 0.42% | +74.5% |
| Q1 2021 | $39,066,000 | -18.0% | 413,005 | +5.6% | 0.24% | -14.1% |
| Q4 2020 | $47,639,000 | +80.2% | 390,967 | +29.2% | 0.28% | +65.5% |
| Q3 2020 | $26,437,000 | +59.8% | 302,619 | +18.2% | 0.17% | +50.0% |
| Q2 2020 | $16,540,000 | +109.9% | 256,078 | +45.2% | 0.11% | +65.2% |
| Q1 2020 | $7,879,000 | +3417.4% | 176,421 | +3107.7% | 0.07% | +3350.0% |
| Q2 2019 | $224,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |